Discover how rare disease innovators can navigate complex care pathways, engage stakeholders early, and build evidence strategies that support successful commercialization, originally written by Natalie Harb, Vice President, Global Launch Excellence, Global Commercial Solutions, IQVIA, and published in PharmaLive.